Baseline sCD@L levels were measured in @ consecutive patients with acute minor stroke and transient ischemic attack , who had previously been enrolled in the Clopidogrel in High-Risk Patients With Acute Nondisabling Cerebrovascular Events ( CHANCE ) trial .